Literature DB >> 27745881

Monthly PCSK9 inhibitors: The CHOICE for prolonged duration of effect.

Luiz Sérgio F de Carvalho1, Hiroshi Yoshida2.   

Abstract

Entities:  

Keywords:  Clinical trials; Hypercholesterolemia; Lipid modifying drugs; PCSK9 inhibitors

Mesh：

Substances：

Year:  2016        PMID： 27745881     DOI： 10.1016/j.atherosclerosis.2016.09.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  1 in total

1.  A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.

Authors:  Hiroshi Yoshida
Journal:  J Atheroscler Thromb       Date:  2017-02-24       Impact factor: 4.928
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.